Skip to main content
Portfolio
TrendingElectionsPoliticsSportsCultureCryptoCommoditiesClimateEconomicsMentionsFinanceTech & Science
PredictLive183AccountSocial
MARKETSINVESTLIVE183
Product
Kalshi ProInvestMarketsIncentive programSmall business hedgingInstitutionsAPI & developers
Company
AboutKalshi ResearchBlogCareersPolicy CenterBrand Kit
Help
Help CenterFAQPrediction marketsFee scheduleTrading hoursRegulatoryTrust Center

© 2026 Kalshi Inc. · All rights reserved
PrivacyData Terms of ServiceTrading ProhibitionsFAQ for Finance Professionals
Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.
  1. Medicine

When will the FDA reclassify BPC-157 to Category 1?



AI Digest · Hims & Hers and Noom launch peptide programs after HHS eases compounding

Not advice · 41m ago

Both telehealth companies will now offer peptide prescriptions to eligible patients. The US Department of Health and Human Services made it easier for pharmacies to offer BPC-157. The Before November contract on an FDA move to Category 1 settled No. The Before 2027 contract is still trading and was unchanged over the last day. Many compounded peptides sold to consumers are experimental and lack FDA approval. Category 1 placement would restore the ability of compounding pharmacies to make BPC-157.

  • STAT

    STAT+: Peptide market poised to explode with new Hims and Noom launches

Chance

5%
▼ 3

5%
▼ 3

No

No

No

No

3 more

When will the FDA reclassify BPC-157 to Category 1?

Before 2027

Odds
7% chance
Max payout
Dec 31, 2026
$0
Before 2027
5%
0%25%50%75%100%MarMayJulSepNov
$149,056 vol
More Science and Technology Markets

Trending Science and Technology markets

Best AI at the end of 2026?Will the U.S. confirm that aliens exist?Anthropic market share this weekWhen will the Riemann hypothesis win the Millennium Prize?When will the Riemann Hypothesis be resolved?Will Anthropic announce a Millennium Prize solution?Open vs. Closed Token Volume (open weights share) todayOpen source share of spend today (Vercel)

Science and Technology hub

All Science and Technology markets